Anna K. Nowak

29.9k total citations · 3 hit papers
358 papers, 11.3k citations indexed

About

Anna K. Nowak is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Anna K. Nowak has authored 358 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Pulmonary and Respiratory Medicine, 130 papers in Oncology and 57 papers in Genetics. Recurrent topics in Anna K. Nowak's work include Occupational and environmental lung diseases (134 papers), Pleural and Pulmonary Diseases (88 papers) and Cancer Immunotherapy and Biomarkers (56 papers). Anna K. Nowak is often cited by papers focused on Occupational and environmental lung diseases (134 papers), Pleural and Pulmonary Diseases (88 papers) and Cancer Immunotherapy and Biomarkers (56 papers). Anna K. Nowak collaborates with scholars based in Australia, United States and United Kingdom. Anna K. Nowak's co-authors include Richard Lake, Bruce Robinson, Michael Byrne, W. Joost Lesterhuis, Arthur W. Musk, Jenette Creaney, Georgia Halkett, Elizabeth Lobb, Michael Millward and Martin R. Stockler and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Anna K. Nowak

336 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

2004 496 citations Anna K. Nowak et al. profile →
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial

2017 304 citations Paul Taylor, Federica Grosso et al. profile →
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

2022 158 citations Laurent Greillier, Anna K. Nowak et al. profile →

Peers

Countries citing papers authored by Anna K. Nowak

Since Specialization

Citations

This map shows the geographic impact of Anna K. Nowak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna K. Nowak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna K. Nowak more than expected).

Fields of papers citing papers by Anna K. Nowak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna K. Nowak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna K. Nowak. The network helps show where Anna K. Nowak may publish in the future.

Co-authorship network of co-authors of Anna K. Nowak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna K. Nowak. A scholar is included among the top collaborators of Anna K. Nowak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna K. Nowak. Anna K. Nowak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model 2025 ·Cancer Immunology Immunotherapy ·(unknown), Synat Keam, Suki Gill, Pejman Rowshanfarzad, Anna K. Nowak, Martin A. Ebert, Alistair Cook	2
2	Unveiling the Unspoken: Exploring Taboo Thoughts and Difficult Experiences Among Carers of People With Brain Cancer 2025 ·Psycho-Oncology ·Emma McDougall, (unknown), Susanne Kjærgaard, Georgia Halkett, Anna K. Nowak, Haryana M. Dhillon, Lauren J. Breen, Karin Piil	1
3	The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma 2024 ·Journal of Thoracic Oncology ·Andrea Wolf, (unknown), Dorothy J. Giroux, Ritu R. Gill, Anna K. Nowak, Andrea Billè, David C. Rice, R. Taylor Ripley, Isabelle Opitz, Françoise Galateau-Sallé, Seiki Hasegawa, Hedy L. Kindler, Harvey I. Pass, Valerie W. Rusch	12
4	The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Proposal for Revision of the TNM Stage Groupings in the Forthcoming (Ninth) Edition of the TNM Classification for Pleural Mesothelioma 2024 ·Journal of Thoracic Oncology ·Anna K. Nowak, Dorothy J. Giroux, (unknown), Adam Rosenthal, Andrea Billè, Ritu R. Gill, Hedy L. Kindler, Harvey I. Pass, David C. Rice, R. Taylor Ripley, Andrea Wolf, Joseph S. Friedberg, Katherine K. Nishimura, Valerie W. Rusch	7
5	What do carers of people with high-grade glioma perceive could improve their preparedness to care, and what additional support do they require? 2024 ·Neuro-Oncology Practice ·(unknown), Georgia Halkett, Emma McDougall, Haryana M. Dhillon, Elizabeth Lobb, Jane Phillips, Peter Hudson, Anna K. Nowak	2
6	A nurse-led intervention for carers of people with high-grade glioma: A case series of carers reporting high distress 2024 ·Neuro-Oncology Practice ·Georgia Halkett, Emma McDougall, (unknown), Jenny Clarke, Haryana M. Dhillon, Elizabeth Lobb, Jane Phillips, Peter Hudson, (unknown), Rachel Campbell, Joanne Shaw, Elisabeth Coyne, Brian Kelly, Tamara Ownsworth, (unknown), Anna K. Nowak	2
7	Out-of-pocket costs for patients diagnosed with high-grade glioma and their carers 2024 ·Neuro-Oncology Practice ·(unknown), Georgia Halkett, Cameron Wright, Moira O’Connor, Anna K. Nowak, Rachael Moorin	0
8	Psychosocial interventions for personality and behavior changes in adults with a brain tumor: A scoping review 2023 ·Neuro-Oncology Practice ·Emma McDougall, Lauren J. Breen, Anna K. Nowak, Haryana M. Dhillon, Georgia Halkett	1
9	A feasibility, safety, and efficacy evaluation of supervised aerobic and resistance exercise for patients with glioblastoma undertaking adjuvant chemoradiotherapy 2023 ·Neuro-Oncology Practice ·Anna K. Nowak, Robert U. Newton, Travis Cruickshank, Prue Cormie, Georgia Halkett, (unknown), Daniel A. Galvão	7
10	Bereavement outcomes of carers of patients with high grade glioma: Experiences of support before and after the death 2023 ·Death Studies ·Elizabeth Lobb, Georgia Halkett, Emma McDougall, Rachel Campbell, Haryana M. Dhillon, Jane Phillips, Anna K. Nowak	5
11	Physical activity and glioma: a case–control study with follow-up for survival 2022 ·Cancer Causes & Control ·(unknown), Yi Yang, Fiona Bruinsma, Anna K. Nowak, Kerrie L. McDonald, Katharine J. Drummond, Mark Rosenthal, Eng‐Siew Koh, Rosemary Harrup, Elizabeth Hovey, David Joseph, Geza Benke, (unknown), Robert J. MacInnis, Roger L. Milne, Graham G. Giles, Claire M. Vajdic, Brigid M. Lynch	1
12	Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice 2022 ·Nature Communications ·Rachael M. Zemek, Wee Loong Chin, Vanessa S. Fear, Ben Wylie, Thomas Casey, (unknown), Caitlin M. Tilsed, Louis Boon, Belinda B. Guo, Anthony Bosco, Alistair R. R. Forrest, Michael Millward, Anna K. Nowak, Richard Lake, Timo Lassmann, W. Joost Lesterhuis	25
13	Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment 2022 ·BMJ Global Health ·Odgerel Chimed‐Ochir, Emma M. Rath, Tatsuhiko Kubo, (unknown), Ro‐Ting Lin, Sugio Furuya, (unknown), Sonja Klebe, Anna K. Nowak, Seong‐Kyu Kang, Ken Takahashi	3
14	Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data 2020 ·BMC Public Health ·Cameron Wright, Anna K. Nowak, Georgia Halkett, Rachael Moorin	1
15	Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment 2019 ·OncoImmunology ·(unknown), (unknown), Alistair Cook, Louis Boon, Ian M. Dick, Anna K. Nowak, Richard Lake, W. Joost Lesterhuis	26
16	Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM) 2019 ·Journal of Patient-Reported Outcomes ·Tito R. Mendoza, Loretta A. Williams, Karen Keating, Jonathan Siegel, Cem Elbi, Anna K. Nowak, Raffit Hassan, Brian J. Cuffel, Charles S. Cleeland	6
17	Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules 2018 ·The Journal of Pathology ·Bo He, Arnaud Jabouille, Veronica Steri, Anna Johansson, Iacovos P. Michael, Venkata Ramana Kotamraju, Reimar Junckerstorff, Anna K. Nowak, Juliana Hamzah, Gabriel Lee, Gabriele Bergers, Ruth Ganß	84
18	Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial 2017 ·Journal of Clinical Oncology ·Federica Grosso, Nicola Steele, Silvia Novello, Anna K. Nowak, Sanjay Popat, Laurent Greillier, Thomas John, Natasha B. Leighl, Martin Reck, Paul Taylor, David Planchard, Jens Benn Sørensen, Mark A. Socinski, Ute von Wangenheim, (unknown), José Barrueco, Nassim Morsli, Giorgio V. Scagliotti	77
19	Cosmesis and breast-related quality of life outcomes following intra-operative radiotherapy for early breast cancer - a sub-study of the TARGIT - a trial 2016 ·UCL Discovery (University College London) ·Tammy Corica, Anna K. Nowak, (unknown), Max Bulsara, Mandy Taylor, Jayant S. Vaidya, Michael Baum, (unknown)	2
20	Evidence Based Medicine - teaching with clinical relevance in an undergraduate medical curriculum 2010 ·UWA Profiles and Research Repository (University of Western Australia) ·Anna K. Nowak, Ian Jacobs, Fiona Lake, Diana Jonas‐Dwyer, Greg Ryan, Sandra Carr	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact